Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: Grand View Research | PRODUCT CODE: 1301040

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1301040

Biochip Market Size, Share & Trends Analysis Report, By Type (DNA Chips, Lab-on-Chip, Cell Arrays, Tissue Arrays, Protein Chips), By End Use, By Region, And Segment Forecasts, 2023 - 2030

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Biochips Market Growth & Trends

The global biochips market size is expected to reach USD 25.92 billion by 2030, registering a CAGR of 12.66% during the forecast period, according to a new report by Grand View Research, Inc. The rising requirement for drug discovery and development coupled with the adoption of personalized medicine is likely to favor the industry's growth. Furthermore, the rise in the implementation of next-generation sequencing by biotechnology companies around the globe is pushing product demand. For instance, in December 2021, Abbott received CE Mark for the i-STAT TBI Plasma test, a portable analyzer for Traumatic Brain Injury (TBI) blood. Hence, the company is permitted to expand its footprint in the European Union. The innovation in sequencing techniques has allowed researchers to decode DNA molecules up to the level of the complete human genome.

Ion Torrent chip by Thermo Fisher Scientific is one of the technologies based on sequencing by the technique of synthesis. The chip is an advancement in the Next-Generation Sequencing (NGS) technology that makes massively parallel sequencing cost-effective for every lab. Hence, the development of biochips to enhance the NGS application is anticipated to support the growth of the industry. Similarly, increasing government-based initiatives to promote the domestic production of biochips is likely to support the growth in the coming years. This strategic initiative is to match the local demand for the product with the supply. For instance, in July 2022, SiPhox, Inc. received a grant worth USD 681,631 from the Baker-Polito Administration.

The financial support is to accelerate the development of a manufacturing facility for the mass production of pluggable photonic biochips. It is estimated to accelerate the output to around 5,000 biochips per month from around 100 per month to match the rising demand from biotech segments including drug discovery, vaccine development, and distributed diagnostics. Such investments are likely to supplement the industry growth in the coming years. The COVID-19 pandemic is estimated to have a positive impact on industry growth during the forecasted period. Various companies collaborated to develop innovative solutions to deal with the pandemic. For instance, in March 2020, SkyWater Technology announced the collaboration with MGI, to supply essential components for COVID-19 sequencing, including microfluidic MEMS devices.

The growing requirement for personalized medicine is likely to become a key application area for the industry in the coming years. Since biochip is emerging as an important component in molecular diagnostics, their use in point-of-care diagnostics is anticipated to smooth the development of personalized medicines. In addition, gene expression profiling through microarrays is expected to enhance the progress of personalized treatment for cancer based on molecular classification. However, the cost involved in the manufacturing of biochips is considerably high, resulting in high pricing for end-users. For instance, Josep Carreras Leukaemia Research Institute (IJC) provides microarray to researchers. The cost of GeneChip Human Gene 2.0 ST for whole-transcript expression analysis & profiling ranges from USD 456 to 593 for fresh samples.

Biochips Market Report Highlights

  • The DNA chips type segment accounted for the largest revenue share in 2022 due to the high demand for rapid and accurate detection of cancer
  • The drug discovery application segment for lab-on-chip is anticipated to grow at a faster rate during the forecast period as the biochip helps lower the overall cost of drug discovery & development
  • The biotechnology and pharmaceutical companies end-user segment captured a significant revenue share in 2022 due to the need for personalized medicines along with the increasing drug discovery & development
  • North America held the largest revenue share in 2022 owing to high R&D investment coupled with the accessibility of capital through venture capitalists for startups and the application development of biochips in the region
  • Asia Pacific is projected to register the fastest CAGR from 2023 to 2030 owing to various initiatives by local governments to promote domestic product manufacturing
Show more
Product Code: GVR-1-68038-077-4

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
  • 1.2. Information Procurement
  • 1.3. Information Or Data Analysis
  • 1.4. Market Scope & Segment Definition
  • 1.5. Market Model
    • 1.5.1. Market Study, By Company Market Share
    • 1.5.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increase in adoption of next-generation sequencing
      • 3.2.1.2. Growing R&D in proteomics and genomics
      • 3.2.1.3. Presence of an extensive drug-development pipeline
      • 3.2.1.4. Increasing adoption of personalized medicine
      • 3.2.1.5. Rapid technological advances in biochip technology
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of manufacturing
      • 3.2.2.2. Lack of knowledge regarding biochips
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Biochip Market: Type Movement Analysis
  • 4.2. DNA Chips
    • 4.2.1. DNA Chips Market, 2018 - 2030 (USD Million)
    • 4.2.2. Cancer Diagnosis and Treatment
      • 4.2.2.1. Cancer Diagnosis and Treatment Market, 2018 - 2030 (USD Million)
    • 4.2.3. Gene Expression
      • 4.2.3.1. Gene Expression Market, 2018 - 2030 (USD Million)
    • 4.2.4. SNP Genotyping
      • 4.2.4.1. SNP Genotyping Market, 2018 - 2030 (USD Million)
    • 4.2.5. Genomics
      • 4.2.5.1. Genomics Market, 2018 - 2030 (USD Million)
    • 4.2.6. Drug Discovery
      • 4.2.6.1. Drug Discovery Market, 2018 - 2030 (USD Million)
    • 4.2.7. Agricultural Biotechnology
      • 4.2.7.1. Agricultural Biotechnology Market, 2018 - 2030 (USD Million)
    • 4.2.8. Others
      • 4.2.8.1. Others Market, 2018 - 2030 (USD Million)
  • 4.3. Protein Chips
    • 4.3.1. Protein Chips Market, 2018 - 2030 (USD Million)
    • 4.3.2. Proteomics
      • 4.3.2.1. Proteomics Market, 2018 - 2030 (USD Million)
    • 4.3.3. Expression Profiling
      • 4.3.3.1. Expression Profiling Market, 2018 - 2030 (USD Million)
    • 4.3.4. Diagnostics
      • 4.3.4.1. Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.3.5. HTS
      • 4.3.5.1. HTS Market, 2018 - 2030 (USD Million)
    • 4.3.6. Drug Discovery
      • 4.3.6.1. Drug Discovery Market, 2018 - 2030 (USD Million)
    • 4.3.7. Others
      • 4.3.7.1. Others Market, 2018 - 2030 (USD Million)
  • 4.4. Lab-on- chips
    • 4.4.1. Lab-on- Chips Market, 2018 - 2030 (USD Million)
    • 4.4.2. Genomics
      • 4.4.2.1. Genomics Market, 2018 - 2030 (USD Million)
    • 4.4.3. IVD & POC
      • 4.4.3.1. IVD & POC Market, 2018 - 2030 (USD Million)
    • 4.4.4. Proteomics
      • 4.4.4.1. Proteomics Market, 2018 - 2030 (USD Million)
    • 4.4.5. Drug Discovery
      • 4.4.5.1. Drug DiscoveryMarket, 2018 - 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others Market, 2018 - 2030 (USD Million)
  • 4.5. Tissue Arrays
    • 4.5.1. Tissue Arrays Market, 2018 - 2030 (USD Million)
  • 4.6. Cell Arrays
    • 4.6.1. Cell Arrays Market, 2018 - 2030 (USD Million)

Chapter 5. End-Use Business Analysis

  • 5.1. Biochip Market: End-Use Movement Analysis
  • 5.2. Academic and Research Institutes
    • 5.2.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
  • 5.3. Pharmaceutical & Biotechnology Companies
    • 5.3.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 5.4. Hospitals and Diagnostics Centers
    • 5.4.1. Hospitals and Diagnostics Centers Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Biochip Market Share By Region, 2022 & 2030
  • 6.2. North America
    • 6.2.1. SWOT Analysis
    • 6.2.2. North America Biochip Market, 2018 - 2030 (USD Million)
    • 6.2.3. U.S.
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Target Disease Prevalence
      • 6.2.3.3. Competitive Scenario
      • 6.2.3.4. U.S. Biochip Market, 2018 - 2030 (USD Million)
    • 6.2.4. Canada
      • 6.2.4.1. Key Country Dynamics
      • 6.2.4.2. Target Disease Prevalence
      • 6.2.4.3. Competitive Scenario
      • 6.2.4.4. Canada Biochip Market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. SWOT Analysis
    • 6.3.2. Europe Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.3. UK
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Target Disease Prevalence
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. UK Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.4. Germany
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Target Disease Prevalence
      • 6.3.4.3. Competitive Scenario
      • 6.3.4.4. Germany Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.5. France
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Target Disease Prevalence
      • 6.3.5.3. Competitive Scenario
      • 6.3.5.4. France Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.6. Italy
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Target Disease Prevalence
      • 6.3.6.3. Competitive Scenario
      • 6.3.6.4. Italy Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.7. Spain
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Target Disease Prevalence
      • 6.3.7.3. Competitive Scenario
      • 6.3.7.4. Spain Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.8. Denmark
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Target Disease Prevalence
      • 6.3.8.3. Competitive Scenario
      • 6.3.8.4. Denmark Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.9. Sweden
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Target Disease Prevalence
      • 6.3.9.3. Competitive Scenario
      • 6.3.9.4. Sweden Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.10. Norway
      • 6.3.10.1. Key Country Dynamics
      • 6.3.10.2. Target Disease Prevalence
      • 6.3.10.3. Competitive Scenario
      • 6.3.10.4. Norway Biochip Market, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. SWOT Analysis
    • 6.4.2. Asia Pacific Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Japan Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.4. China
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. China Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.5. India
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Target Disease Prevalence
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. India Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Target Disease Prevalence
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Australia Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Target Disease Prevalence
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. Thailand Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.8. South Korea
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Target Disease Prevalence
      • 6.4.8.3. Competitive Scenario
      • 6.4.8.4. South Korea Biochip Market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. SWOT Analysis
    • 6.5.2. Latin America Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.3. Brazil
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Brazil Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Mexico Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.5. Argentina
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Target Disease Prevalence
      • 6.5.5.3. Competitive Scenario
      • 6.5.5.4. Argentina Biochip Market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. SWOT Analysis
    • 6.6.2. MEA Biochip Market, 2018 - 2030 (USD Million)
    • 6.6.3. South Africa
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. South Africa Biochip Market, 2018 - 2030 (USD Million)
    • 6.6.4. Saudi Arabia
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. Saudi Arabia Biochip Market, 2018 - 2030 (USD Million)
    • 6.6.5. UAE
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. UAE Biochip Market, 2018 - 2030 (USD Million)
    • 6.6.6. Kuwait
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Target Disease Prevalence
      • 6.6.6.3. Competitive Scenario
      • 6.6.6.4. Kuwait Biochip Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Share Analysis, 2022
  • 7.4. Company Profiles/Listing
    • 7.4.1. Thermo Fisher Scientific, Inc
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Agilent Technologies, Inc.
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. PerkinElmer Inc.
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Illumina, Inc.
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Bio-Rad Laboratories, Inc.
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Standard BioTools
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. GE Healthcare
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. LI-COR, Inc.
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. QIAGEN
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Randox Laboratories Ltd
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
Show more
Product Code: GVR-1-68038-077-4

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Regulatory Framework
  • TABLE 4 Global Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 5 Global Biochip Market, By End-Use, 2018 - 2030 (USD Million
  • TABLE 6 Global Biochip Market, By Region, 2018 - 2030 (USD Million)
  • TABLE 7 North America Biochip Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 8 North America Biochip Market, By Type, 2018 - 2030 (USD Million),
  • TABLE 9 North America Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 10 U.S. Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 11 U.S. Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 12 Canada Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 13 Canada Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 14 Europe Biochip Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 15 Europe Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 16 Europe Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 17 UK Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 18 UK Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 19 Germany Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 20 Germany Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 21 France Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 22 France Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 23 Spain Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 24 Spain Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 25 Italy Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 26 Italy Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 27 Denmark Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 28 Denmark Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 29 Norway Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 30 Norway Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 31 Sweden Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 32 Sweden Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 33 Asia Pacific Biochip Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 34 Asia Pacific Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 35 Asia Pacific Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 36 China Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 37 China Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 38 Japan Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 39 Japan Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 40 India Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 41 India Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 42 South Korea Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 43 South Korea Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 44 Australia Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 45 Australia Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 46 Thailand Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 47 Thailand Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 48 Latin America Biochip Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 49 Latin America Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 50 Latin America Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 51 Brazil Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 52 Brazil Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 53 Mexico Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 54 Mexico Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 55 Argentina Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 56 Argentina Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 57 MEA Biochip Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 58 MEA Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 59 MEA Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 60 South Africa Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 61 South Africa Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 62 UAE Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 63 UAE Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 64 Saudi Arabia Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 65 Saudi Arabia Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 66 Kuwait Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 67 Kuwait Biochip Market, By End-Use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 Market formulation & validation
  • FIG. 7 biochip market segmentation.
  • FIG. 8 Market snapshot, 2022
  • FIG. 9 Market trends & outlook
  • FIG. 10 Market driver relevance analysis (current & future impact)
  • FIG. 11 Market restraint relevance analysis (current & future impact)
  • FIG. 12 PESTEL analysis
  • FIG. 13 Porter's five forces analysis
  • FIG. 14 Global biochip market: Type movement analysis
  • FIG. 15 Global biochip market, for DNA chips, 2018 - 2030 (USD Million)
  • FIG. 16 Global biochip market, for cancer diagnosis and treatment, 2018 - 2030 (USD Million)
  • FIG. 17 Global biochip market, for gene expression, 2018 - 2030 (USD Million)
  • FIG. 18 Global biochip market, for SNP genotyping, 2018 - 2030 (USD Million)
  • FIG. 19 Global biochip market, for genomics, 2018 - 2030 (USD Million)
  • FIG. 20 Global biochip market, for drug discovery, 2018 - 2030 (USD Million)
  • FIG. 21 Global biochip market, for agricultural biotechnology, 2018 - 2030 (USD Million)
  • FIG. 22 Global biochip market, for others, 2018 - 2030 (USD Million)
  • FIG. 23 Global biochip market, for protein chips, 2018 - 2030 (USD Million)
  • FIG. 24 Global biochip market, for proteomics, 2018 - 2030 (USD Million)
  • FIG. 25 Global biochip market, for expression profiling, 2018 - 2030 (USD Million)
  • FIG. 26 Global biochip market, for diagnostics, 2018 - 2030 (USD Million)
  • FIG. 27 Global biochip market, for HTS, 2018 - 2030 (USD Million)
  • FIG. 28 Global biochip market, for drug discovery, 2018 - 2030 (USD Million)
  • FIG. 29 Global biochip market, for others, 2018 - 2030 (USD Million)
  • FIG. 30 Global biochip market, for lab-on-chip, 2018 - 2030 (USD Million)
  • FIG. 31 Global biochip market, for genomics, 2018 - 2030 (USD Million)
  • FIG. 32 Global biochip market, for IVD& POC, 2018 - 2030 (USD Million)
  • FIG. 33 Global biochip market, for proteomics, 2018 - 2030 (USD Million)
  • FIG. 34 Global biochip market, for drug discovery, 2018 - 2030 (USD Million)
  • FIG. 35 Global biochip market, for others, 2018 - 2030 (USD Million)
  • FIG. 36 Global biochip market, for tissue arrays, 2018 - 2030 (USD Million)
  • FIG. 37 Global biochip market, for cell arrays, 2018 - 2030 (USD Million)
  • FIG. 38 Global biochip market: End-Use movement analysis
  • FIG. 39 Global biochip market, for academic and research institutes, 2018 - 2030 (USD Million)
  • FIG. 40 Global biochip market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
  • FIG. 41 Global biochip market, for hospitals and diagnostics centers, 2018 - 2030 (USD Million)
  • FIG. 42 Global biochip market, for others, 2018 - 2030 (USD Million)
  • FIG. 43 Regional marketplace: Key takeaways
  • FIG. 44 Regional outlook, 2022 & 2030
  • FIG. 45 Global biochip market: Region movement analysis
  • FIG. 46 North America biochip market, 2018 - 2030 (USD Million)
  • FIG. 47 U.S. biochip market, 2018 - 2030 (USD Million)
  • FIG. 48 Canada biochip market, 2018 - 2030 (USD Million)
  • FIG. 49 Europe biochip market, 2018 - 2030 (USD Million)
  • FIG. 50 Germany biochip market, 2018 - 2030 (USD Million)
  • FIG. 51 UK biochip market, 2018 - 2030 (USD Million)
  • FIG. 52 France biochip market, 2018 - 2030 (USD Million)
  • FIG. 53 Italy biochip market, 2018 - 2030 (USD Million)
  • FIG. 54 Spain biochip market, 2018 - 2030 (USD Million)
  • FIG. 55 Denmark biochip market, 2018 - 2030 (USD Million)
  • FIG. 56 Sweden biochip market, 2018 - 2030 (USD Million)
  • FIG. 57 Norway biochip market, 2018 - 2030 (USD Million)
  • FIG. 58 Asia Pacific biochip market, 2018 - 2030 (USD Million)
  • FIG. 59 Japan biochip market, 2018 - 2030 (USD Million)
  • FIG. 60 China biochip market, 2018 - 2030 (USD Million)
  • FIG. 61 India biochip market, 2018 - 2030 (USD Million)
  • FIG. 62 Australia biochip market, 2018 - 2030 (USD Million)
  • FIG. 63 South Korea biochip market, 2018 - 2030 (USD Million)
  • FIG. 64 Thailand biochip market, 2018 - 2030 (USD Million)
  • FIG. 65 Latin America biochip market, 2018 - 2030 (USD Million)
  • FIG. 66 Brazil biochip market, 2018 - 2030 (USD Million)
  • FIG. 67 Mexico biochip market, 2018 - 2030 (USD Million)
  • FIG. 68 Argentina biochip market, 2018 - 2030 (USD Million)
  • FIG. 69 Middle East and Africa biochip market, 2018 - 2030 (USD Million)
  • FIG. 70 South Africa biochip market, 2018 - 2030 (USD Million)
  • FIG. 71 Saudi Arabia biochip market, 2018 - 2030 (USD Million)
  • FIG. 72 UAE biochip market, 2018 - 2030 (USD Million)
  • FIG. 73 Kuwait biochip market, 2018 - 2030 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!